1/ Here's my review on adaptive immunity to COVID-19 and SARS-CoV-2. I hope you find it useful. It was a lot of work. Thanks to Prof Alex Sette @SetteLab and others for direct contributions and broader input over the year!
cell.com/cell/fulltext/… @CellCellPress Image
2/ And thanks to all of the amazing scientists and labs around the world that have done so much work making incredible progress on these challenging COVID-19 immunology topics in the past year!
3/ FYI, here's the right version of Figure 1. It should be updated in the next version posted online. Image
Adding to this. I have been asked for clean copies of Figure 2 for people to use in slide presentations. Here it is, feel free to use.

cell.com/cell/fulltext/… Image
4/ Updated PDF for "Adaptive Immunity to SARS-CoV-2 and COVID-19" now available at Cell.
cell.com/cell/fulltext/… Image

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Shane Crotty

Shane Crotty Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @profshanecrotty

9 Jan
1/ “I think this [study] is really important because there is a lot of fear and uncertainty at the moment about this specific question.”

“[the results are] not surprising, but it’s been really important to see some data.” 

washingtonpost.com/health/2021/01…
2/ Definitely good news to see these data on the Pfizer vaccine working against the 501 variant. If anything, the vaccine works better against this variant.
biorxiv.org/content/10.110…
3/ It isn't the end of the story, because the UK / SA variants have mutations in addition to 501, but these vaccine data are an important piece of the puzzle. As noted in the article, more is expected from labs in the coming weeks, but these results are expected & encouraging.
Read 4 tweets
9 Jan
1/ One pre-print on B117 viral loads (i.e., B.1.1.7 SARS-CoV-2 ) found substantially higher viral loads (median 10-100 times). Another UK study found 3 times higher viral loads in people with B117 (Bonsall/Golubchik study).
medrxiv.org/content/10.110…

coronavirus-fraser-group.org/files/files/up…
2/
3/
Read 7 tweets
6 Jan
1.  Our COVID-19 paper on Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection is out today in @ScienceMagazine !
science.sciencemag.org/content/early/…
@ljiresearch @SetteLab @Dani6020
2. The immune system can remember viruses. And there are multiple different parts of the immune system that can remember a virus in different ways, so the immune system can fight the virus in multiple ways.
3. Our data shows that the body’s immune system remembers novel coronavirus for at least 8 months after COVID-19, and multiple different branches of the immune system remember the virus.
Read 8 tweets
31 Dec 20
1.  I am convinced that the new "UK variant" of SARS-CoV-2 (B.1.1.7) is a big problem. I look forward to seeing more epidemiology by more labs (not my area), but the overall picture plus these new viral load data now have me convinced. (my PhD was RNA virology)
Thread
2.  An analysis of 641 COVID-19 cases found "S-negative" (B.1.1.7 inferred) cases had 10 to 100-times higher nasal viral loads than 'regular' COVID-19. Virologically, that is a massive difference. It could easily explain higher transmissibility.
doi.org/10.1101/2020.1…
3. The authors of that work are appropriately cautious in their interpretations (e.g. they didn't directly sequence confirm B.1.1.7 cases), and it will be very valuable to see similar studies from other sites. But, I find the data compelling.
Read 7 tweets
17 Dec 20
A bit more in depth look at the Moderna FDA data.

1. 94% effective at preventing COVID-19

That matches the earlier data and public statements
fda.gov/media/144434/d…
(1/6)
2. Prevents severe COVID-19

Zero cases in the vaccinated group. 30 severe cases of COVID-19 in the placebo group.
(2/6)
3. Worked the same in older adults and other subgroups

That matches the earlier data and public statements.
(3/6)
Read 6 tweets
29 Nov 20
Got lots of interest in my RNA vaccine explainer yesterday. The most common follow up questions generally fell into two categories, well stated in the tweet below. I will answer both. 1/5

First, to paraphrase: “Isn’t it strange for the immune system to deal with a viral protein from RNA in host cells?” Actually, the human immune system has spent millions of years evolving to recognize viruses this way. (Really, vertebrates have spent 500 million years doing this!)
Viruses regularly express their proteins on infected human cells, and the immune system specifically recognizes those foreign viral molecules. Indeed, many viruses are RNA viruses (they use RNA as their genetic material!), so the immune system is specifically good at this job.
Read 5 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!